Jim Cramer Reflected on These 17 Stocks

Page 2 of 16

15. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 69

Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer reflected on. When asked about the stock during the lightning round, Cramer replied that he is holding out hope for the company’s “central nervous system drug.”

“Bristol Myers, never seen it this cheap. We’re holding it. I did have high hopes for their, what, what I would say is their central nervous system drug. It better work. If it doesn’t work, we’re going to get rid of it, and it will be a disappointment, and it will be a shame.”

Bristol-Myers (NYSE:BMY) develops and markets biopharmaceutical products targeting cancer, cardiovascular conditions, immune disorders, and neurological diseases. The company’s portfolio includes Eliquis, Opdivo, Revlimid, and other treatments for serious and chronic illnesses. During a June episode, Cramer showed disappointment in the stock, as he commented:

“Bristol Myers, Charitable Trust owns it. So far, we’re not happy with COBENFY. It’s a little disappointing. We need to see that stock back up at 60.”

Page 2 of 16